Codiak BioSciences
Latest round
- Series C
Last raised
- Nov 2017
Total raised
- $169M
Investors
- 11
About Codiak BioSciences
Codiak BioSciences, Inc.Codiak BioSciences specializes in exosome-based therapeutics, seeking to innovate medical treatment solutions. Founded in 2015 and headquartered in Cambridge, US, the company has undergone a significant pivot to focus on engineered exosomes since inception.Codiak BioSciences specializes in exosome-based therapeutics, leveraging its proprietary EngEx™ platform to develop and manufacture engineered exosomes for various medical applications. Their primary focus is on delivering targeted therapies for oncology and other diseases, enhancing treatment efficacy through exosome-mediated drug delivery.21 mn.75 mn, to advance initial product candidates into clinical trials and further develop its exosome therapeutic platform. There are initiatives to expand into specific markets in the United States and select European regions where there is a demand for advanced therapeutic solutions. The company is also focused on launching new engineered exosome products aimed at addressing unmet medical needs in oncology within the upcoming years.
Who invested in Codiak BioSciences
11 investors across 3 rounds
See all investors in Codiak BioSciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Codiak BioSciences
Who invested in Codiak BioSciences?
Codiak BioSciences has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Codiak BioSciences raised?
Codiak BioSciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Codiak BioSciences last raise money?
Codiak BioSciences's most recent round on record is a Series C, in Nov 2017.
What does Codiak BioSciences do?
Codiak BioSciences is a biotechnology company.
Where is Codiak BioSciences headquartered?
Codiak BioSciences is headquartered in Cambridge, US.
Which VCs invest in companies like Codiak BioSciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Codiak BioSciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Codiak BioSciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.